| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―13 |
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions |
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei, Awaji Y. Safhi, Sivakumar S. Moni |
| 2 |
[GO] |
2024―Mar―27 |
Subgingival Plaque as a Potential Reservoir for SARS-CoV-2 Virus in Patients Recovered from COVID-19 Infection: A Cross-sectional Study |
Lekha Ashokkumar, Deepak Moses Ravindran, Balaji S. K. |
| 3 |
[GO] |
2024―Jan―10 |
Cost-effectiveness and Side Effects of Using Heparin and Enoxaparin as a Treatment for COVID-19-associated Coagulopathy |
Nurul Iska Ulmarika Idris, Abdul Khairul Rizki Purba, Arifa Mustika, Anna Surgean Veterini, Mochamad Yusuf Alsagaff, Mohammad Qorib |
| 4 |
[GO] |
2023―Jan―31 |
Targeting TLR-4 Signaling to Treat COVID-19-induced Acute Kidney Injury |
Meaad A. Almazmomi, Mohammed Alsieni |
| 5 |
[GO] |
2023―Jan―19 |
Delayed Extensive Local Reaction to the mRNA-1273 Vaccine against SARS-CoV-2: A Case Report |
Renato Ferreira-da-Silva, Inês Ribeiro-Vaz, Ana Marta Silva, Fernando Nunes, Manuela Morato, Jorge Junqueira Polónia, Paulo Guedes |
| 6 |
[GO] |
2022―Dec―02 |
Progress Update on the Epidemiology of COVID-19 Variants and the Assessment Status of Developed Vaccines |
Katharigatta N. Venugopala |
| 7 |
[GO] |
2022―Jul―07 |
Adverse Drug Reactions with Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis |
Smrati Tiwari, Zahaan Vakil |
| 8 |
[GO] |
2022―May―04 |
COVID-19 and Substance Use: A Scientometric Assessment of Global Publications During 2020 and 2021 |
Sandeep Grover, B.M. Gupta, K.K. Mueen Ahmed |
| 9 |
[GO] |
2021―Nov―24 |
A mini review: Mucormycosis in coronavirus disease-19, host-iron assimilation, and probiotics as novel therapy |
Ankit Bhardwaj, Vandana Roy, Indu Priyadarshini |
| 10 |
[GO] |
2021―Nov―24 |
2-deoxy-d-glucose: A ray of hope in covid pandemic |
DhritiKumar Brahma, Priyotosh Banerjee, IndraniDevi Sarma, DasguptaHimadri Sekhar, Melambha Surong |
| 11 |
[GO] |
2020―Sep―11 |
Critical review and analysis of approval of favipiravir for restricted emergency use in mild-to-moderate COVID-19 |
Arunkumar Radhakrishnan, Ruckmani Arunachalam, Abinaya Elango |
